Literature DB >> 22495864

Collagen type V polymorphism in spontaneous quadriceps tendon ruptures.

Olimpio Galasso1, Enrico Iaccino, Luca Gallelli, Ida Perrotta, Francesco Conforti, Giuseppe Donato, Giorgio Gasparini.   

Abstract

Spontaneous simultaneous bilateral quadriceps tendon rupture is associated with multiple medical conditions and pharmacological treatments; however, identifying prior risk factors is impossible in most cases. Achilles tendon and anterior cruciate ligament ruptures are associated with collagen, type V, alpha 1 (COL5A1) polymorphism. This genetic variant may be implicated quadriceps tendon rupture. The COL5A1 encodes the protein for pro-α1 chains of the low-abundance heterotrimeric type V collagen. In most noncartilaginous tissues, type V collagen is a quantitatively minor component of type I collagen that has been implicated in the regulation of the size and configuration of type I collagen fibrils. The functional significance of COL5A1 polymorphism in relation to type V collagen expression or activity has not been determined.This article describes a patient with COL5A1 polymorphism and spontaneous simultaneous quadriceps tendon rupture. However, genetic and histologic studies performed on blood and tendon tissues and 3 consecutive sex- and age-matched controls showed a statistically significant reduction in collagen type V expression and an alteration in collagen structure in the tendon. These findings might explain the pathomechanisms of spontaneous tendon ruptures associated with COL5A1 polymorphism. Copyright 2012, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22495864     DOI: 10.3928/01477447-20120327-31

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  1 in total

Review 1.  Genetic Factors in Tendon Injury: A Systematic Review of the Literature.

Authors:  Natalie H Vaughn; Hayk Stepanyan; Robert A Gallo; Aman Dhawan
Journal:  Orthop J Sports Med       Date:  2017-08-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.